Patents by Inventor Johnathan Mark Lancaster

Johnathan Mark Lancaster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER
    Publication number: 20180238890
    Abstract: The subject invention concerns methods using a panel of proteins to detect, diagnose, and monitor therapy during treatment of ovarian cancer in a female patient. The proteins were identified using proteomics analyses of plasma samples obtained preoperatively from ovarian cancer patients versus those of healthy control women. Such a panel has utility for the diagnosis of ovarian cancer, screening for ovarian cancer and possibly therapeutic monitoring.
    Type: Application
    Filed: September 28, 2017
    Publication date: August 23, 2018
    Inventors: REBECCA SUTPHEN, JOHNATHAN MARK LANCASTER
  • HUMAN CANCER MICRO-RNA EXPRESSION PROFILES PREDICTIVE OF CHEMO-RESPONSE
    Publication number: 20180207191
    Abstract: Disclosed are identified and successfully targeted microRNAs (miRNAs) associated with human cancer cell line response to a range of anti-cancer agents. The strategy of integrating in vitro miRNA expression and drug sensitivity data not only aid in the characterization of determinants of cytotoxic response, but also in the identification of novel therapeutic targets.
    Type: Application
    Filed: August 13, 2017
    Publication date: July 26, 2018
    Inventors: JOHNATHAN MARK LANCASTER, YIN XIONG, NING CHEN
  • METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER
    Publication number: 20140162891
    Abstract: The subject invention concerns methods using a panel of proteins to detect, diagnose, and monitor therapy during treatment of ovarian cancer in a female patient. The proteins were identified using proteomics analyses of plasma samples obtained preoperatively from ovarian cancer patients versus those of healthy control women. Such a panel has utility for the diagnosis of ovarian cancer, screening for ovarian cancer and possibly therapeutic monitoring.
    Type: Application
    Filed: July 22, 2013
    Publication date: June 12, 2014
    Inventors: Rebecca SUTPHEN, Johnathan Mark LANCASTER
  • Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response
    Publication number: 20130059015
    Abstract: Disclosed are identified and successfully targeted microRNAs (miRNAs) associated with human cancer cell line response to a range of anti-cancer agents. The strategy of integrating in vitro miRNA expression and drug sensitivity data not only aid in the characterization of determinants of cytotoxic response, but also in the identification of novel therapeutic targets.
    Type: Application
    Filed: March 11, 2011
    Publication date: March 7, 2013
    Applicant: H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
    Inventors: Johnathan Mark Lancaster, Yin Xiong, Ning Chen
  • BAD PATHWAY GENE SIGNATURE
    Publication number: 20130011393
    Abstract: The invention provides materials and methods for prognosing cancer, and predicting an individual's responsiveness to cancer treatments, methods of treating cancer, and materials and methods for obtaining BAD pathway gene expression profiles useful in carrying out the methods of the invention.
    Type: Application
    Filed: January 12, 2011
    Publication date: January 10, 2013
    Inventors: Johnathan Mark Lancaster, Dung-Tsa Chen, Yin Xiong
  • METHODS AND MATERIALS FOR DETECTION, DIAGNOSIS AND MANAGEMENT OF OVARIAN CANCER
    Publication number: 20100190662
    Abstract: The subject invention concerns methods using a panel of proteins to detect, diagnose, and monitor therapy during treatment of ovarian cancer in a female patient. The proteins were identified using proteomics analyses of plasma samples obtained preoperatively from ovarian cancer patients versus those of healthy control women. Such a panel has utility for the diagnosis of ovarian cancer, screening for ovarian cancer and possibly therapeutic monitoring.
    Type: Application
    Filed: January 25, 2008
    Publication date: July 29, 2010
    Inventors: Rebecca Sutphen, Johnathan Mark Lancaster